Nicole Sweeny
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Nicole Sweeny is currently Director at Monopar Therapeutics, Inc. and Chief Commercial Officer at KalVista Pharmaceuticals, Inc. Formerly, Ms. Sweeny was Vice President-US Marketing at Shire Plc from 2017 to 2019, Vice President-Franchise Head at Takeda Pharmaceuticals U.S.A., Inc. from 2019 to 2020, and Chief Commercial Officer at Praxis Precision Medicines, Inc. from 2020 to 2023.
Ms. Sweeny completed undergraduate education at Boston College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/05/2026 | 59 291 ( 0,12 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KALVISTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 25/07/2023 |
| MONOPAR THERAPEUTICS INC. | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Corporate Officer/Principal | 31/03/2023 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01/07/2020 |
| SHIRE | Corporate Officer/Principal | 01/01/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Monopar Therapeutics, Inc.
Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national